Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-22 Sale | 2025-10-24 4:38 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 2,595 | $19.03 | $49,383 | 217,958 (Direct) | View |
| 2025-10-22 Sale | 2025-10-24 4:36 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,520 | $19.03 | $47,956 | 200,814 (Direct) | View |
| 2025-10-08 Sale | 2025-10-10 4:03 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 1,272 | $16.3 | $20,734 | 220,553 (Direct) | View |
| 2025-10-08 Sale | 2025-10-10 4:01 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 1,585 | $16.3 | $25,836 | 203,334 (Direct) | View |
| 2025-07-23 Sale | 2025-07-25 5:11 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,805 | $18.15 | $50,911 | 204,919 (Direct) | View |
| 2025-07-23 Sale | 2025-07-25 5:10 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 2,385 | $18.15 | $43,288 | 221,825 (Direct) | View |
| 2025-07-09 Sale | 2025-07-11 4:15 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 1,160 | $17.24 | $19,998 | 224,210 (Direct) | View |
| 2025-07-09 Sale | 2025-07-11 4:13 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 1,519 | $17.24 | $26,188 | 207,724 (Direct) | View |
| 2025-04-23 Sale | 2025-04-25 4:17 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 1,925 | $14.79 | $28,471 | 209,243 (Direct) | View |
| 2025-04-23 Sale | 2025-04-25 4:15 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 2,349 | $14.79 | $34,742 | 225,370 (Direct) | View |
| 2025-04-16 Sale | 2025-04-17 4:08 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 2,993 | $14.89 | $44,566 | 396,774 (Direct) | View |
| 2025-04-16 Sale | 2025-04-17 4:07 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 8,321 | $14.89 | $123,900 | 1,178,191 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 4:08 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 5,004 | $12.99 | $65,002 | 211,168 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 4:07 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 6,169 | $12.99 | $80,135 | 227,719 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 4:06 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 11,063 | $12.99 | $143,708 | 399,767 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 4:05 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 28,094 | $12.99 | $364,941 | 1,186,512 (Direct) | View |
| 2025-03-07 Sale | 2025-03-11 4:18 pm | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 8,000 | $19.6 | $156,769 | 91,913 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:06 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 2,055 | $20.86 | $42,867 | 357,353 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:05 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 2,814 | $20.86 | $58,700 | 321,952 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:04 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 15,439 | $20.86 | $322,058 | 948,786 (Direct) | View |
| 2025-01-22 Sale | 2025-01-24 4:23 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,195 | $23.59 | $51,780 | 139,991 (Direct) | View |
| 2025-01-22 Sale | 2025-01-24 4:22 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 2,657 | $23.59 | $62,679 | 132,314 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-28 Option Award | 2025-07-30 5:56 pm | N/A 2035-07-28 | Immunovant Inc. | IMVT | Venker Eric Chief Executive Officer | 2,964,900 | $0 | 2,964,900 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 7:30 pm | N/A 2035-05-01 | Immunovant Inc. | IMVT | Girao Tiago Chief Financial Officer | 501,893 | $0 | 501,893 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 7:30 pm | N/A 2035-05-01 | Immunovant Inc. | IMVT | Bauer Jake Director | 60,250 | $0 | 60,250 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 7:30 pm | N/A 2035-05-01 | Immunovant Inc. | IMVT | Susman Robert Graham Director | 60,250 | $0 | 60,250 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:55 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer | 122,318 | $0 | 232,274 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:53 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 183,478 | $0 | 293,434 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:51 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 183,478 | $0 | 323,469 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:50 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 244,637 | $0 | 376,951 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:48 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 214,058 | $0 | 536,010 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:46 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 640,215 | $0 | 1,589,001 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:44 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Pande Atul Director | 23,788 | $0 | 130,451 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:43 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 23,788 | $0 | 143,373 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:41 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 23,788 | $0 | 115,701 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:39 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director | 23,788 | $0 | 144,851 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:37 pm | N/A 2035-04-01 | Immunovant Inc. | IMVT | Torti Frank Director | 292,964 | $0 | 928,638 (Direct) | View |